News Focus
News Focus
icon url

DewDiligence

10/15/21 4:00 PM

#239977 RE: DewDiligence #239976

Other nations don’t appear to have the same safety concern that the FDA does about JAK inhibitors.
icon url

DewDiligence

12/10/21 9:51 AM

#240758 RE: DewDiligence #239976

EU approves PFE’s Cibinqo (abrocitinib) for atopic dermatitis:

https://finance.yahoo.com/news/european-commission-approves-pfizer-cibinqo-142700528.html

Cibinqo figures to be a very big-selling drug if it can gain approval from the FDA; it is under FDA review for AD now (#msg-165038886).

Please see #msg-166380532 for background.